Upregulation of liprin-α1 protein in the temporal neocortex of intractable epileptic patients and experimental rats

Synapse

Volumn 65, Issue 8, 2011, Pages 742-750

  Yin, Huan ^a   Wang, Linyuan ^b   Xiao, Fei ^a   Huang, Zuchun ^a   Huang, Yuanyuan ^a   Zhou, Chunlei ^a   Han, Yanbing ^a   Tao, Shuxin ^a   Yang, Hui ^c   Wang, Xuefeng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO   (United States)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Epilepsy; Liprin 1; Rat; Synapse

Indexed keywords

LIPRIN ALPHA1; NERVE PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INTRACTABLE EPILEPSY; MALE; NEOCORTEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEIZURE; SPRAGUE DAWLEY RAT; SYNAPSE; TEMPORAL CORTEX; TEMPORAL LOBE; TEMPORAL LOBE EPILEPSY; UPREGULATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; ANIMALS; BLOTTING, WESTERN; EPILEPSY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOCORTEX; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION; YOUNG ADULT;

EID: 79957854338     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20894     Document Type: Article

References (25)

1. Ayala GF, Spencer WA, Gumnit RJ. 1971. Penicillin as an epileptogenic agent: Effect on an isolated synapse. Science 171: 915-917.
2. Fang M, Liu GW, Pan YM, Shen L, Li CS, Xi ZQ, Xiao F, Wang L, Chen D, Wang XF. 2010. Abnormal expression and spatiotemporal change of Slit2 in neurons and astrocytes in temporal lobe epileptic foci: A study of epileptic patients and experimental animals. Brain Res 1324: 14-23.
3. Feng G, Xiao F, Lu Y, Huang Z, Yuan J, Xiao Z, Xi Z, Wang X. 2009. Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epilepsy. J Mol Neurosci 39: 354-359.
4. French JA. 2007. Refractory epilepsy: Clinical overview. Epilepsia 48( Supp 1): 3-7.
5. Hoogenraad CC, Feliu-Mojer MI, Spangler SA, Milstein AD, Dunah AW, Hung AY, Sheng M. 2007. Liprinalpha1 degradation by calcium/calmodulin-dependent protein kinase II regulates LAR receptor tyrosine phosphatase distribution and dendrite development. Dev Cell 12: 587-602.
6. Kwan P, Brodie MJ. 2000. Early identification of refractory epilepsy. N Engl J Med 342: 314-319.
7. Majores M, Schoch S, Lie A, Becker AJ. 2007. Molecular neuropathology of temporal lobe epilepsy: Complementary approaches in animal models and human disease tissue. Epilepsia 48( Supp 2): 4-12.
8. Nadler JV, Perry BW, Gentry C, Cotman CW. 1980. Loss and reacquisition of hippocampal synapses after selective destruction of CA3-CA4 afferents with kainic acid. Brain Res 191: 387-403.
9. Pan Y, Liu G, Fang M, Shen L, Wang L, Han Y, Shen D, Wang X. 2010. Abnormal expression of netrin-G2 in temporal lobe epilepsy neurons in humans and a rat model. Exp Neurol 224: 340-346.
10. Patel LS, Wenzel HJ, Schwartzkroin PA. 2004. Physiological and morphological characterization of dentate granule cells in the p35 knock-out mouse hippocampus: Evidence for an epileptic circuit. J Neurosci 24: 9005-9014.
11. Racine RJ. 1972. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32: 281-294.
12. Samuels BA, Hsueh YP, Shu T, Liang H, Tseng HC, Hong CJ, Su SC, Volker J, Neve RL, Yue DT, Tsai LH. 2007. Cdk5 promotes synaptogenesis by regulating the subcellular distribution of the MAGUK family member CASK. Neuron 56: 823-837.
13. Schmidt D, Loscher W. 2005. Drug resistance in epilepsy: Putative neurobiologic and clinical mechanisms. Epilepsia 46: 858-877.
14. Schoch S, Gundelfinger ED. 2006. Molecular organization of the presynaptic active zone. Cell Tissue Res 326: 379-391.
15. Serra-Pages C, Medley QG, Tang M, Hart A, Streuli M. 1998. Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. J Biol Chem 273: 15611-15620.
16. Shen JC, Unoki M, Ythier D, Duperray A, Varticovski L, Kumamoto K, Pedeux R, Harris CC. 2007. Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1. Cancer Res 67: 2552-2558.
17. Shin H, Wyszynski M, Huh KH, Valtschanoff JG, Lee JR, Ko J, Streuli M, Weinberg RJ, Sheng M, Kim E. 2003. Association of the kinesin motor KIF1A with the multimodular protein liprin-alpha. J Biol Chem 278: 11393-11401.
18. Spangler SA, Hoogenraad CC. 2007. Liprin-alpha proteins: Scaffold molecules for synapse maturation. Biochem Soc Trans 35(Part 5): 1278-1282.
19. Stryker E, Johnson KG. 2007. LAR, liprin alpha and the regulation of active zone morphogenesis. J Cell Sci 120(Part 21): 3723-3728.
20. Wyszynski M, Kim E, Dunah AW, Passafaro M, Valtschanoff JG, Serra-Pages C, Streuli M, Weinberg RJ, Sheng M. 2002. Interaction between GRIP and liprin-alpha/SYD2 is required for AMPA receptor targeting. Neuron 34: 39-52.
21. Xi ZQ, Xiao F, Yuan J, Wang XF, Wang L, Quan FY, Liu GW. 2009. Gene expression analysis on anterior temporal neocortex of patients with intractable epilepsy. Synapse 63: 1017-1028.
22. Xiao F, Wang XF, Li JM, Xi ZQ, Lu Y, Wang L, Zeng Y, Guan LF, Yuan J. 2008. Overexpression of N-WASP in the brain of human epilepsy. Brain Res 1233: 168-175.
23. Xiao Z, Gong Y, Wang XF, Xiao F, Xi ZQ, Lu Y, Sun HB. 2009. Altered expression of synaptotagmin I in temporal lobe tissue of patients with refractory epilepsy. J Mol Neurosci 38: 193-200.
24. Yuan J, Wang LY, Li JM, Cao NJ, Wang L, Feng GB, Xue T, Lu Y, Wang XF. 2010. Altered expression of the small guanosine triphosphatase RhoA in human temporal lobe epilepsy. J Mol Neurosci 42: 53-58.
25. Zurner M, Schoch S. 2009. The mouse and human Liprin-alpha family of scaffolding proteins: Genomic organization, expression profiling and regulation by alternative splicing. Genomics 93: 243-253.